Abstract: A method for veterinary administration of medication to an animal, particularly a horse, is disclosed. The method involves inserting a capsule containing the medication, which is a liquid formulation, into a device connected to a tubular chamber. An atomizer is activated to atomize the medication, producing atomized medication. Before administration, a force is applied to a mask placed over the animal's muzzle, connected to the chamber. The atomized medication is then delivered to the animal. The liquid formulation, in some instances, comprises cells, cellular byproducts, or cell-derived products such as stem cells or products from human mesenchymal stem cells. This formulation may lack preservatives and may encompass peptides, proteins, growth factors, cytokines, exosomes, and extracellular vesicles. The delivery mechanism may involve deflating an air bladder to convey the atomized medication.

Abstract: The invention pertains to a capsule system for use with a medical device designed to administer atomized medication to patients. The system features a chamber containing the medication and an atomizer at a lower end for efficient drug delivery. Notably, the system incorporates a fluid sensor and electrical contacts to ensure proper operation and medication delivery. The capsule's design includes a housing with an asymmetrical transverse cross-sectional shape for unique fitting, and a tapered wall to direct medication towards the atomizer. The capsule may also connect to an external container or include a stopper for refilling medication. A specific embodiment features two chambers with a rupturing element to facilitate medication transfer. Another embodiment includes a removable container, like a vial, within the first chamber. This novel system provides improvements in accuracy, versatility, and user-friendliness, overcoming limitations in prior art.

Abstract: The invention relates to organopolysiloxanes comprising at least one structural unit with at least one C8-28 alkyl group and at least one urea group, a method for their preparation, a preparation comprising the organopolysiloxane, and the use as a hydrophobizing agent.

Abstract: Preparations of a polyurethane and/or polyurea and a copolymer which are hydrophobic contain at least one conversion product (S), at least one copolymer (C), optionally at least one (blocked) polyisocyanate, optionally a solvent, and optionally at least one surface-active substance. The conversion product (S) may be the reaction product of at least one compound (A) with at least one unblocked or at least partially blocked di-, tri- or polyisocyanate (IC). The compound A may be the reaction product of a polyhydric alcohol with a carboxylic acid or with an alkylisocyanate, or a reaction product of an alkanolamine and/or alkylamine (a3) with a carboxylic acid and/or alkylisocyanate. The highly hydrophobic preparations may be applied to textiles without negatively influencing a subsequent adhesion of the textile substrate or the membrane permeability of the substrate even after thermal treatment, and exhibit very good wash permanence on the substrates.

Abstract: The invention relates to preparations comprising a polyurethane and/or polyurea and a copolymer as well as their use as hydrophobing agents,

Abstract: The invention relates to preparations containing at least one blocked polyisocyanate and at least one oleophobic and/or hydrophobic finishing agent, and to the use of said preparation for the oleophobic and/or hydrophobic finishing of sheet material, in particular textiles.

Abstract: The invention relates to preparations containing at least one blocked polyisocyanate and at least one oleophobic and/or hydrophobic finishing agent, and to the use of said preparation for the oleophobic and/or hydrophobic finishing of sheet material, in particular textiles.